Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Wang Philip Li, Executive. Director active across 2 companies, notably Shanghai Bio-heart Biological Technology Co., Ltd. - B. Cumulatively, 66 disclosures have been recorded. Activity tracked since 17 April 2026. The latest transaction was disclosed on 24 July 2026 (Purchase). Regulator: HKEX. The full history is free.
Companies and markets linked to Wang Philip Li
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10,000 shares@ HK$2.560.3% of flowShareXHKGHKEX:DA20260617E00070
25 of 66 declarations
About Wang Philip Li
Wang Philip Li is a Dirigeant and a director of Shanghai Bio-heart Biological Technology Co., Ltd. - B -H Sh and Shanghai Bio-heart Biological Technology Co., Ltd. - B, on XHKG. Across 58 filings in total, the 58 sampled filings run from 2026-04-17 to 2026-07-14 and are all purchases, with a total amount of EUR 1224983.